Recall events
/
Event 79606
Event summary
Timeline bucket March 28, 2018
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Elroselabs Inc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
3 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 3
Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06
D-0621-2018
Recall number D-0621-2018
Initiated March 28, 2018
Classification Class II
Status Terminated
Quantity Unknown
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations
Code information All product within expiry
Distribution pattern Nationwide.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2495]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 3
Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.
D-0622-2018
Recall number D-0622-2018
Initiated March 28, 2018
Classification Class II
Status Terminated
Quantity Unknown
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations
Code information All product within expiry
Distribution pattern Nationwide.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2106]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 3
Conzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3%, 1.5 oz. tube, OTC, Manufactured for Elrose Labs, Inc., Sanford, FL
D-0623-2018
Recall number D-0623-2018
Initiated March 28, 2018
Classification Class II
Status Terminated
Quantity Unknown
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
cGMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall cGMP Deviations
Code information All product within expiry
Distribution pattern Nationwide.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1390]
FDA event record
· Exact recall-number query on openFDA
